| Year |
Citation |
Score |
| 2023 |
He L, Ioannidis A, Arambula E, Hoffman CJ, Joshi P, Kathiravan A, Whitelegge J, Liau LM, Kornblum HI, Pajonk F. Activation of the mevalonate pathway in response to anti-cancer treatments drives glioblastoma recurrences through activation of Rac-1. Biorxiv : the Preprint Server For Biology. PMID 37546917 DOI: 10.1101/2023.07.23.550205 |
0.419 |
|
| 2022 |
Muthukrishnan SD, Kawaguchi R, Nair P, Prasad R, Qin Y, Johnson M, Wang Q, VanderVeer-Harris N, Pham A, Alvarado AG, Condro MC, Gao F, Gau R, Castro MG, Lowenstein PR, ... ... Pajonk F, et al. P300 promotes tumor recurrence by regulating radiation-induced conversion of glioma stem cells to vascular-like cells. Nature Communications. 13: 6202. PMID 36261421 DOI: 10.1038/s41467-022-33943-0 |
0.33 |
|
| 2020 |
He L, Bhat K, Duhacheck-Muggy S, Ioannidis A, Zhang L, Nguyen NT, Moatamed NA, Pajonk F. Tumor necrosis factor receptor signaling modulates carcinogenesis in a mouse model of breast cancer. Neoplasia (New York, N.Y.). 23: 197-209. PMID 33383310 DOI: 10.1016/j.neo.2020.12.007 |
0.37 |
|
| 2020 |
Bhat K, Saki M, Vlashi E, Cheng F, Duhachek-Muggy S, Alli C, Yu G, Medina P, He L, Damoiseaux R, Pellegrini M, Zemke NR, Nghiemphu PL, Cloughesy TF, Liau LM, ... ... Pajonk F, et al. The dopamine receptor antagonist trifluoperazine prevents phenotype conversion and improves survival in mouse models of glioblastoma. Proceedings of the National Academy of Sciences of the United States of America. PMID 32358191 DOI: 10.1073/Pnas.1920154117 |
0.455 |
|
| 2020 |
Bhat K, Medina P, He L, Zhang L, Saki M, Ioannidis A, Nguyen NT, Sodhi SS, Sung D, Magyar CE, Liau LM, Kornblum HI, Pajonk F. 1-[(4-Nitrophenyl)sulfonyl]-4-phenylpiperazine Treatment After Brain Irradiation Preserves Cognitive Function in Mice. Neuro-Oncology. PMID 32291451 DOI: 10.1093/Neuonc/Noaa095 |
0.359 |
|
| 2020 |
He L, Bhat K, Medina P, Alli C, Saki M, Cheng F, Pajonk F. Abstract P3-03-07: TNFR-signaling in breast cancer development Cancer Research. 80. DOI: 10.1158/1538-7445.Sabcs19-P3-03-07 |
0.447 |
|
| 2019 |
Saki M, Bhat K, Sodhi SS, Nguyen NT, Kornblum HI, Pajonk F. Effects of Brain Irradiation in Immune-Competent and Immune-Compromised Mouse Models. Radiation Research. PMID 31774721 DOI: 10.1667/Rr15373.1 |
0.348 |
|
| 2019 |
Duhachek-Muggy S, Bhat K, Medina P, Cheng F, He L, Alli C, Saki M, Sree Muthukrishnan SD, Ruffenach G, Eghbali M, Vlashi E, Pajonk F. Radiation Mitigation of the Intestinal Acute Radiation Injury in Mice by 1-[(4-Nitrophenyl)Sulfonyl]-4-Phenylpiperazine. Stem Cells Translational Medicine. PMID 31464098 DOI: 10.1002/Sctm.19-0136 |
0.452 |
|
| 2019 |
Zhang L, Bailleul J, Yazal T, Dong K, Sung D, Dao A, Gosa L, Nathanson D, Bhat K, Duhachek-Muggy S, Alli C, Dratver MB, Pajonk F, Vlashi E. PK-M2-mediated metabolic changes in breast cancer cells induced by ionizing radiation. Breast Cancer Research and Treatment. PMID 31372790 DOI: 10.1007/S10549-019-05376-9 |
0.517 |
|
| 2019 |
Bhat K, Duhachek-Muggy S, Ramanathan R, Saki M, Alli C, Medina P, Damoiseaux R, Whitelegge J, McBride WH, Schaue D, Vlashi E, Pajonk F. 1-(4-nitrobenzenesulfonyl)-4-penylpiperazine increases the number of Peyer's patch-associated regenerating crypts in the small intestines after radiation injury. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. 132: 8-15. PMID 30825974 DOI: 10.1016/J.Radonc.2018.11.011 |
0.363 |
|
| 2019 |
Bhat K, Sandler K, Duhachek-Muggy S, Alli C, Cheng F, Moatamed NA, Magyar CE, Du L, Li G, McCloskey S, Vlashi E, Pajonk F. Serum erythropoietin levels, breast cancer and breast cancer-initiating cells. Breast Cancer Research : Bcr. 21: 17. PMID 30700319 DOI: 10.1186/S13058-019-1100-9 |
0.472 |
|
| 2018 |
Zhang L, Bochkur Dratver M, Yazal T, Dong K, Nguyen A, Yu G, Dao A, Bochkur Dratver M, Duhachek-Muggy S, Bhat K, Alli C, Pajonk F, Vlashi E. Mebendazole potentiates radiation therapy in triple-negative breast cancer. International Journal of Radiation Oncology, Biology, Physics. PMID 30196056 DOI: 10.1016/J.Ijrobp.2018.08.046 |
0.512 |
|
| 2017 |
Kirsch DG, Diehn M, Kesarwala AH, Maity A, Morgan MA, Schwarz JK, Bristow R, Demaria S, Eke I, Griffin RJ, Haas-Kogan D, Higgins GS, Kimmelman AC, Kimple RJ, Lombaert IM, ... ... Pajonk F, et al. The Future of Radiobiology. Journal of the National Cancer Institute. PMID 29126306 DOI: 10.1093/Jnci/Djx231 |
0.413 |
|
| 2017 |
Qi XS, Pajonk F, McCloskey S, Low DA, Kupelian P, Steinberg M, Sheng K. Radioresistance of the breast tumor is highly correlated to its level of cancer stem cell and its clinical implication for breast irradiation. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. PMID 28923575 DOI: 10.1016/J.Radonc.2017.08.019 |
0.474 |
|
| 2017 |
Duhachek-Muggy S, Bhat K, Vlashi E, Pajonk F. Growth Differentiation Factor 11 does not Mitigate the Lethal Effects of Total-Abdominal Irradiation. Radiation Research. PMID 28829672 DOI: 10.1667/Rr14628.1 |
0.453 |
|
| 2017 |
Ludwig K, Belle JL, Sperry J, Vlashi E, Pajonk F, Kornblum H. RBIO-06. NADPH OXIDASE (NOX) PROMOTES RADIATION RESISTANCE THROUGH OXIDATION OF PTEN IN GLIOBLASTOMA Neuro-Oncology. 19: vi218-vi218. DOI: 10.1093/Neuonc/Nox168.884 |
0.323 |
|
| 2016 |
Vlashi E, Chen AM, Boyrie S, Yu G, Nguyen A, Brower PA, Hess CB, Pajonk F. Radiation-Induced Dedifferentiation of Head and Neck Cancer Cells Into Cancer Stem Cells Depends on Human Papillomavirus Status. International Journal of Radiation Oncology, Biology, Physics. 94: 1198-206. PMID 27026319 DOI: 10.1016/J.Ijrobp.2016.01.005 |
0.344 |
|
| 2016 |
Dratver MB, Siu RT, Boyer S, Nguyen A, Frohnen P, Pajonk F, Vlashi E. Abstract A07: Inhibiting radiation-induced reprogramming of breast cancer cells via metabolic perturbation Molecular Cancer Research. 14. DOI: 10.1158/1557-3125.Metca15-A07 |
0.578 |
|
| 2016 |
Vlashi E, Chen AM, Boyrie S, Yu G, Nguyen A, Brower PA, Hess CB, Pajonk F. Radiation-Induced Dedifferentiation of Head and Neck Cancer Cells into Cancer Stem Cells Depends on Human Papillomavirus Status International Journal of Radiation Oncology Biology Physics. 94: 1198-1206. DOI: 10.1016/j.ijrobp.2016.01.005 |
0.424 |
|
| 2015 |
Yu V, Nguyen D, Pajonk F, Kaprealian T, Kupelian P, Steinberg M, Low D, Sheng K. SU-D-BRB-06: Treating Glioblastoma Multiforme (GBM) as a Chronic Disease: Implication of Temporal-Spatial Dose Fractionation Optimization Including Cancer Stem Cell Dynamics. Medical Physics. 42: 3212. PMID 26127187 DOI: 10.1118/1.4923879 |
0.437 |
|
| 2015 |
Yu VY, Nguyen D, Pajonk F, Kupelian P, Kaprealian T, Selch M, Low DA, Sheng K. Incorporating cancer stem cells in radiation therapy treatment response modeling and the implication in glioblastoma multiforme treatment resistance. International Journal of Radiation Oncology, Biology, Physics. 91: 866-75. PMID 25752402 DOI: 10.1016/J.Ijrobp.2014.12.004 |
0.528 |
|
| 2015 |
Vlashi E, Pajonk F. The metabolic state of cancer stem cells-a valid target for cancer therapy? Free Radical Biology & Medicine. 79: 264-8. PMID 25450330 DOI: 10.1016/J.Freeradbiomed.2014.10.732 |
0.442 |
|
| 2015 |
Vlashi E, Pajonk F. Cancer stem cells, cancer cell plasticity and radiation therapy. Seminars in Cancer Biology. 31: 28-35. PMID 25025713 DOI: 10.1016/J.Semcancer.2014.07.001 |
0.517 |
|
| 2015 |
Yu VY, Nguyen D, Pajonk F, Kaprealian TB, Kupelian PA, Steinberg ML, Low D, Sheng K. Treating Glioblastoma Multiforme as a Chronic Disease: Mathematical Dose Fractionation Schedule Optimization and Modeling With Cancer Stem Cell Dynamics International Journal of Radiation Oncology Biology Physics. 93. DOI: 10.1016/J.Ijrobp.2015.07.430 |
0.402 |
|
| 2014 |
Qi S, Pajonk F, McCloskey S, Low D, Kupelian P, Steinberg M, Sheng K. WE-E-BRE-10: Level of Breast Cancer Stem Cell Correlated with Tumor Radioresistence: An Indication for Individualized Breast Cancer Therapy Adapted to Cancer Stem Cell Fractions. Medical Physics. 41: 506. PMID 28037663 DOI: 10.1118/1.4889439 |
0.499 |
|
| 2014 |
Yu V, Nguyen D, Kupelian P, Kaprealian T, Selch M, Low D, Pajonk F, Sheng K. SU-C-BRE-03: Dual Compartment Mathematical Modeling of Glioblastoma Multiforme (GBM). Medical Physics. 41: 94. PMID 28036550 DOI: 10.1118/1.4889709 |
0.446 |
|
| 2014 |
Vlashi E, Lagadec C, Vergnes L, Reue K, Frohnen P, Chan M, Alhiyari Y, Dratver MB, Pajonk F. Metabolic differences in breast cancer stem cells and differentiated progeny. Breast Cancer Research and Treatment. 146: 525-34. PMID 25007966 DOI: 10.1007/S10549-014-3051-2 |
0.745 |
|
| 2014 |
Lagadec C, Vlashi E, Bhuta S, Lai C, Mischel P, Werner M, Henke M, Pajonk F. Tumor cells with low proteasome subunit expression predict overall survival in head and neck cancer patients. Bmc Cancer. 14: 152. PMID 24593279 DOI: 10.1186/1471-2407-14-152 |
0.481 |
|
| 2014 |
Lagadec C, Vlashi E, Frohnen P, Alhiyari Y, Chan M, Pajonk F. The RNA-binding protein Musashi-1 regulates proteasome subunit expression in breast cancer- and glioma-initiating cells. Stem Cells (Dayton, Ohio). 32: 135-44. PMID 24022895 DOI: 10.1002/Stem.1537 |
0.727 |
|
| 2014 |
Qi X, Pajonk F, Low D, Kupelian P, McCloskey S, Sheng K. Radioresistance of the Breast Tumor is Highly Correlated to Its Level of Cancer Stem Cell International Journal of Radiation Oncology Biology Physics. 90. DOI: 10.1016/J.Ijrobp.2014.05.167 |
0.479 |
|
| 2013 |
Vlashi E, Lagadec C, Chan M, Frohnen P, McDonald AJ, Pajonk F. Targeted elimination of breast cancer cells with low proteasome activity is sufficient for tumor regression. Breast Cancer Research and Treatment. 141: 197-203. PMID 24013708 DOI: 10.1007/S10549-013-2688-6 |
0.497 |
|
| 2013 |
Pajonk F, Vlashi E. Characterization of the stem cell niche and its importance in radiobiological response. Seminars in Radiation Oncology. 23: 237-41. PMID 24012337 DOI: 10.1016/J.Semradonc.2013.05.007 |
0.449 |
|
| 2013 |
Lagadec C, Vlashi E, Alhiyari Y, Phillips TM, Bochkur Dratver M, Pajonk F. Radiation-induced Notch signaling in breast cancer stem cells. International Journal of Radiation Oncology, Biology, Physics. 87: 609-18. PMID 23992604 DOI: 10.1016/J.Ijrobp.2013.06.2064 |
0.742 |
|
| 2013 |
Steinberg M, McBride WH, Vlashi E, Pajonk F. National Institutes of Health funding in radiation oncology: a snapshot. International Journal of Radiation Oncology, Biology, Physics. 86: 234-40. PMID 23523324 DOI: 10.1016/J.Ijrobp.2013.01.030 |
0.375 |
|
| 2012 |
Lagadec C, Pajonk F. Catch-22: does breast cancer radiotherapy have negative impacts too? Future Oncology (London, England). 8: 643-5. PMID 22764760 DOI: 10.2217/Fon.12.55 |
0.411 |
|
| 2012 |
Lagadec C, Vlashi E, Della Donna L, Dekmezian C, Pajonk F. Radiation-induced reprogramming of breast cancer cells. Stem Cells (Dayton, Ohio). 30: 833-44. PMID 22489015 DOI: 10.1002/Stem.1058 |
0.542 |
|
| 2012 |
Lagadec C, Dekmezian C, Bauché L, Pajonk F. Oxygen levels do not determine radiation survival of breast cancer stem cells. Plos One. 7: e34545. PMID 22479642 DOI: 10.1371/Journal.Pone.0034545 |
0.526 |
|
| 2012 |
Della Donna L, Lagadec C, Pajonk F. Radioresistance of prostate cancer cells with low proteasome activity. The Prostate. 72: 868-74. PMID 21932424 DOI: 10.1002/Pros.21489 |
0.374 |
|
| 2012 |
Lagadec CH, Vlashi E, Dekmezian C, Pajonk F. Abstract 416: Radiation-induced reprograming of breast cancer cells Cancer Research. 72: 416-416. DOI: 10.1158/1538-7445.Am2012-416 |
0.526 |
|
| 2012 |
Kang J, Selch M, Cloughesy T, Kupelian P, Pajonk F, Wang J, Agazaryan N, Lee P. Radiation of Potential Local Cancer Stem Cell Niches Improves Survival of Patients With Glioblastoma Multiforme International Journal of Radiation Oncology*Biology*Physics. 84: S6-S7. DOI: 10.1016/J.Ijrobp.2012.07.023 |
0.497 |
|
| 2011 |
Vlashi E, Lagadec C, Vergnes L, Matsutani T, Masui K, Poulou M, Popescu R, Della Donna L, Evers P, Dekmezian C, Reue K, Christofk H, Mischel PS, Pajonk F. Metabolic state of glioma stem cells and nontumorigenic cells. Proceedings of the National Academy of Sciences of the United States of America. 108: 16062-7. PMID 21900605 DOI: 10.1073/Pnas.1106704108 |
0.445 |
|
| 2011 |
Potts BC, Albitar MX, Anderson KC, Baritaki S, Berkers C, Bonavida B, Chandra J, Chauhan D, Cusack JC, Fenical W, Ghobrial IM, Groll M, Jensen PR, Lam KS, Lloyd GK, ... ... Pajonk F, et al. Marizomib, a proteasome inhibitor for all seasons: preclinical profile and a framework for clinical trials. Current Cancer Drug Targets. 11: 254-84. PMID 21247382 DOI: 10.2174/156800911794519716 |
0.341 |
|
| 2011 |
Lagadec CH, Donna LD, Vlashi E, Dekmezian C, Brocks T, Pajonk F. Abstract 4372: Radiation induces Notch-dependent de novo generation of breast cancer stem cells via expression of OCT-4/SOX2/NANOG Cancer Research. 71: 4372-4372. DOI: 10.1158/1538-7445.Am2011-4372 |
0.571 |
|
| 2011 |
Chann L, Vlashi E, Lorenza D, Dekmezian C, Pajonk F. P1-04-06: Ionizing Radiation Reprograms Non-Tumorigenic Cancer Cells into Cancer Stem Cells. Cancer Research. 71. DOI: 10.1158/0008-5472.Sabcs11-P1-04-06 |
0.527 |
|
| 2010 |
Evers P, Lee PP, DeMarco J, Agazaryan N, Sayre JW, Selch M, Pajonk F. Irradiation of the potential cancer stem cell niches in the adult brain improves progression-free survival of patients with malignant glioma. Bmc Cancer. 10: 384. PMID 20663133 DOI: 10.1186/1471-2407-10-384 |
0.475 |
|
| 2010 |
Vlashi E, Mattes M, Lagadec C, Donna LD, Phillips TM, Nikolay P, McBride WH, Pajonk F. Differential Effects of the Proteasome Inhibitor NPI-0052 against Glioma Cells. Translational Oncology. 3: 50-5. PMID 20165695 DOI: 10.1593/Tlo.09244 |
0.461 |
|
| 2010 |
Lagadec C, Vlashi E, Della Donna L, Meng Y, Dekmezian C, Kim K, Pajonk F. Survival and self-renewing capacity of breast cancer initiating cells during fractionated radiation treatment. Breast Cancer Research : Bcr. 12: R13. PMID 20158881 DOI: 10.1186/Bcr2479 |
0.52 |
|
| 2010 |
Vlashi E, Pajonk F. Targeted cancer stem cell therapies start with proper identification of the target. Molecular Cancer Research : McR. 8: 291; author reply 29. PMID 20145040 DOI: 10.1158/1541-7786.Mcr-09-0505 |
0.41 |
|
| 2010 |
Pajonk F, Vlashi E, McBride WH. Radiation resistance of cancer stem cells: the 4 R's of radiobiology revisited. Stem Cells (Dayton, Ohio). 28: 639-48. PMID 20135685 DOI: 10.1002/Stem.318 |
0.524 |
|
| 2010 |
Lagadec CH, Vlashi E, Donna LD, Meng Y, Dekmezian C, Kim K, Pajonk F. Abstract 4287: Survival and self-renewing capacity of breast cancer initiating cells during fractionated radiation treatment Cancer Research. 70: 4287-4287. DOI: 10.1158/1538-7445.Am10-4287 |
0.492 |
|
| 2010 |
Vlashi E, Lagadec C, Donna LD, Meng Y, Dekmezian C, Pajonk F. Abstract 4241: Glioma stem cells perform oxidative phosphorylation, while the rest of glioma cells perform aerobic glycolysis Cancer Research. 70: 4241-4241. DOI: 10.1158/1538-7445.Am10-4241 |
0.432 |
|
| 2010 |
Donna LD, Lagadec C, Vlashi E, Meng Y, Dekmezian C, Souda P, Whitelegge JP, Pajonk F. Abstract 1063: The activity of the 26S proteasome is modulated during the different phases of the cell cycle Cancer Research. 70: 1063-1063. DOI: 10.1158/1538-7445.Am10-1063 |
0.414 |
|
| 2010 |
Lagadec C, Donna LD, Vlashi E, Dekmezian C, Pajonk F. Abstract PD02-10: Radiation Induces Notch-DependentDe NovoGeneration of Breast Cancer Stem Cells Cancer Research. 70. DOI: 10.1158/0008-5472.Sabcs10-Pd02-10 |
0.56 |
|
| 2009 |
Vlashi E, McBride WH, Pajonk F. Radiation responses of cancer stem cells. Journal of Cellular Biochemistry. 108: 339-42. PMID 19623582 DOI: 10.1002/Jcb.22275 |
0.552 |
|
| 2009 |
Woodward WA, Bristow RG, Clarke MF, Coppes RP, Cristofanilli M, Duda DG, Fike JR, Hambardzumyan D, Hill RP, Jordan CT, Milas L, Pajonk F, Curran WJ, Dicker AP, Chen Y. Radiation Therapy Oncology Group translational research program stem cell symposium: incorporating stem cell hypotheses into clinical trials. International Journal of Radiation Oncology, Biology, Physics. 74: 1580-91. PMID 19540073 DOI: 10.1016/J.Ijrobp.2009.03.047 |
0.427 |
|
| 2009 |
Vlashi E, Kim K, Lagadec C, Donna LD, McDonald JT, Eghbali M, Sayre JW, Stefani E, McBride W, Pajonk F. In vivo imaging, tracking, and targeting of cancer stem cells. Journal of the National Cancer Institute. 101: 350-9. PMID 19244169 DOI: 10.1093/Jnci/Djn509 |
0.499 |
|
| 2009 |
Lagadec C, Vlashi E, Donna LD, McBride W, Pajonk F. Low proteasome activity as a means to track and target breast cancer stem cells in-vivo. Cancer Research. 69: 5055. DOI: 10.1158/0008-5472.Sabcs-5055 |
0.522 |
|
| 2009 |
Lagadec C, Vlashi E, Donna LD, Pajonk F. The Response of Breast Cancer Initiating Cells to Fractionated Radiation. Cancer Research. 69: 1153-1153. DOI: 10.1158/0008-5472.Sabcs-09-1153 |
0.511 |
|
| 2007 |
Phillips TM, Kim K, Vlashi E, McBride WH, Pajonk F. Effects of recombinant erythropoietin on breast cancer-initiating cells. Neoplasia (New York, N.Y.). 9: 1122-9. PMID 18084619 DOI: 10.1593/Neo.07694 |
0.488 |
|
| 2006 |
Pajonk F, Grumann T, McBride WH. The proteasome inhibitor MG-132 protects hypoxic SiHa cervical carcinoma cells after cyclic hypoxia/reoxygenation from ionizing radiation. Neoplasia (New York, N.Y.). 8: 1037-41. PMID 17217621 DOI: 10.1593/Neo.06634 |
0.417 |
|
| 2006 |
Phillips TM, McBride WH, Pajonk F. The response of CD24(-/low)/CD44+ breast cancer-initiating cells to radiation. Journal of the National Cancer Institute. 98: 1777-85. PMID 17179479 DOI: 10.1093/Jnci/Djj495 |
0.492 |
|
| 2006 |
Pajonk F, Riedisser A, Henke M, McBride WH, Fiebich B. The effects of tea extracts on proinflammatory signaling. Bmc Medicine. 4: 28. PMID 17140430 DOI: 10.1186/1741-7015-4-28 |
0.338 |
|
| 2006 |
Henke M, Mattern D, Pepe M, Bézay C, Weissenberger C, Werner M, Pajonk F. Do erythropoietin receptors on cancer cells explain unexpected clinical findings? Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 24: 4708-13. PMID 17028293 DOI: 10.1200/Jco.2006.06.2737 |
0.417 |
|
| 2005 |
Pajonk F, van Ophoven A, Weissenberger C, McBride WH. The proteasome inhibitor MG-132 sensitizes PC-3 prostate cancer cells to ionizing radiation by a DNA-PK-independent mechanism. Bmc Cancer. 5: 76. PMID 16001975 DOI: 10.1186/1471-2407-5-76 |
0.371 |
|
| 2005 |
Pajonk F, van Ophoven A, McBride WH. Hyperthermia-induced proteasome inhibition and loss of androgen receptor expression in human prostate cancer cells. Cancer Research. 65: 4836-43. PMID 15930304 DOI: 10.1158/0008-5472.Can-03-2749 |
0.404 |
|
| 2005 |
Pajonk F, Scholber J, Fiebich B. Hypericin - An inhibitor of proteasome function Cancer Chemotherapy and Pharmacology. 55: 439-446. PMID 15672261 DOI: 10.1007/S00280-004-0933-8 |
0.364 |
|
| 2004 |
Pajonk F, Weil A, Sommer A, Suwinski R, Henke M. The erythropoietin-receptor pathway modulates survival of cancer cells. Oncogene. 23: 8987-91. PMID 15480420 DOI: 10.1038/Sj.Onc.1208140 |
0.434 |
|
| 2004 |
McBride WH, Chiang CS, Olson JL, Wang CC, Hong JH, Pajonk F, Dougherty GJ, Iwamoto KS, Pervan M, Liao YP. A sense of danger from radiation. Radiation Research. 162: 1-19. PMID 15222781 DOI: 10.1667/Rr3196 |
0.369 |
|
| 2003 |
McBride WH, Iwamoto KS, Syljuasen R, Pervan M, Pajonk F. The role of the ubiquitin/proteasome system in cellular responses to radiation. Oncogene. 22: 5755-73. PMID 12947384 DOI: 10.1038/Sj.Onc.1206676 |
0.492 |
|
| 2002 |
Pajonk F, Riess K, Sommer A, McBride WH. N-acetyl-L-cysteine inhibits 26S proteasome function: implications for effects on NF-kappaB activation. Free Radical Biology & Medicine. 32: 536-43. PMID 11958954 DOI: 10.1016/S0891-5849(02)00743-8 |
0.332 |
|
| 2002 |
McBride WH, Pajonk F, Chiang CS, Sun JR. NF-kappa B, cytokines, proteasomes, and low-dose radiation exposure. Military Medicine. 167: 66-7. PMID 11873521 DOI: 10.1093/Milmed/167.Suppl_1.66 |
0.393 |
|
| 2001 |
Pajonk F, McBride WH. The proteasome in cancer biology and treatment Radiation Research. 156: 447-459. PMID 11604057 DOI: 10.1667/0033-7587(2001)156[0447:Tpicba]2.0.Co;2 |
0.427 |
|
| 2001 |
Pervan M, Pajonk F, Sun JR, Withers HR, McBride WH. Molecular pathways that modify tumor radiation response. American Journal of Clinical Oncology. 24: 481-5. PMID 11586100 DOI: 10.1097/00000421-200110000-00013 |
0.43 |
|
| 2001 |
Pajonk F, Schlessmann S, Guttenberger R, Henke M. Epithelial cells in the peripheral blood of patients with cancer of the head and neck: Incidence, detection and possible clinical significance Radiotherapy and Oncology. 59: 213-217. PMID 11325451 DOI: 10.1016/S0167-8140(00)00315-7 |
0.401 |
|
| 2001 |
Pajonk F, McBride WH. Ionizing radiation affects 26s proteasome function and associated molecular responses, even at low doses Radiotherapy and Oncology. 59: 203-212. PMID 11325450 DOI: 10.1016/S0167-8140(01)00311-5 |
0.411 |
|
| 2001 |
Riess K, Sommer A, McBride W, Pajonk F. Hyperthermia inhibits 26s proteasome function and promotes androgen-independent growth of LnCaP prostate cancer cells International Journal of Radiation Oncology*Biology*Physics. 51: 239-240. DOI: 10.1016/S0360-3016(01)02260-X |
0.333 |
|
| 2000 |
Pajonk F, Pajonk K, McBride WH. Apoptosis and radiosensitization of Hodgkin cells by proteasome inhibition International Journal of Radiation Oncology Biology Physics. 47: 1025-1032. PMID 10863075 DOI: 10.1016/S0360-3016(00)00516-2 |
0.425 |
|
| 1999 |
Pajonk F, Pajonk K, McBride WH. Inhibition of NF-κB, clonogenicity, and radiosensitivity of human cancer cells Journal of the National Cancer Institute. 91: 1956-1960. PMID 10564680 DOI: 10.1093/Jnci/91.22.1956 |
0.422 |
|
| 1999 |
Henke M, Guttenberger R, Barke A, Pajonk F, Pötter R, Frommhold H. Erythropoietin for patients undergoing radiotherapy: A pilot study Radiotherapy and Oncology. 50: 185-190. PMID 10368042 DOI: 10.1016/S0167-8140(98)00115-7 |
0.334 |
|
| 1996 |
Pajonk F, Schmidt J, Witucki G, Henke M. 414Variation of radiation induced expression of nitric oxide synthase mRNA in colon cancer cell lines SW 480 and SW 620 Radiotherapy and Oncology. 40. DOI: 10.1016/S0167-8140(96)80423-3 |
0.42 |
|
| Show low-probability matches. |